ViroGates A/S
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ViroGates A/S - overview
Established
2001
Location
-, -, Denmark
Primary Industry
Biotechnology
About
ViroGates A/S is a Danish company dedicated to the development and commercialization of innovative biomarker products, particularly suPARnostic®, which aids in assessing health risks and immune system activation. Founded in 2001 in Denmark, ViroGates A/S specializes in biomarker solutions, offering products that reflect immune system and inflammation levels. The company has undergone management exit in July 2007, marking a significant transition. ViroGates specializes in developing and commercializing the suPARnostic® biomarker product, which measures the soluble urokinase plasminogen activator receptor (suPAR) in blood.
This biomarker is crucial for assessing health risks and offering personalized intervention strategies. suPARnostic® finds applications in acute care triage, clinical trials, and wellness programs, serving healthcare professionals, hospitals, and research institutions across North America, Europe, and parts of Asia. In 2023, ViroGates reported a revenue of DKK 810,366. 70 and an EBITDA of DKK -1,818,316.
60, reflecting their financial performance during the year. ViroGates A/S aims to leverage its recent funding of DKK 14. 5 mn from investors including PreSeed Ventures and SEED Capital to enhance product offerings and expand into new markets. The company is actively developing new products to support health assessments, with a strategic focus on increasing its presence in North America and Asia by 2025.
Upcoming developments are set to refine their existing offerings and introduce advanced biomarker testing solutions.
Current Investors
PreSeed Ventures, Missionpharma A/S
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.virogates.com
Total Amount Raised
Subscriber access only
ViroGates A/S - timeline of key events
ViroGates A/S - financials
| Fiscal Year Ended | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 597,276 | 377,513 | 933,289 | 981,190 | 3,104,347 | 3,592,468 | 3,685,744 | 2,441,166 | 3,316,000 | 3,582,000 | 5,354,000 | 7,656,000 | - | - | - |
| % Revenue Growth (YoY) | - | (36.8%) | 147.2% | 5.1% | 216.4% | 15.7% | 2.6% | (33.8%) | 35.8% | 8.0% | 49.5% | 43.0% | - | - | - |
| EBITDA (USD) | (8,183,404) | (10,594,112) | (8,837,647) | (8,792,952) | (7,243,615) | (5,254,862) | (6,837,800) | (7,572,776) | (17,977,000) | (19,607,000) | (19,500,000) | (18,573,000) | - | - | - |
| Operating Income (USD) | (9,175,684) | (10,902,263) | (9,167,934) | (9,413,498) | (7,326,389) | (5,354,364) | (6,936,800) | (7,691,276) | (18,102,000) | (19,723,000) | (19,729,000) | (18,790,000) | - | - | - |
| Operating Margin | (1536.3%) | (2887.9%) | (982.3%) | (959.4%) | (236.0%) | (149.0%) | (188.2%) | (315.1%) | (545.9%) | (550.6%) | (368.5%) | (245.4%) | - | - | - |
| % EBITDA Margin | (1370.1%) | (2806.3%) | (946.9%) | (896.2%) | (233.3%) | (146.3%) | (185.5%) | (310.2%) | (542.1%) | (547.4%) | (364.2%) | (242.6%) | - | - | - |
| NET Income (USD) | (8,996,616) | (10,876,611) | (7,924,563) | (14,221,255) | (5,725,508) | (4,069,838) | (5,402,900) | (5,987,162) | (16,986,000) | (18,797,000) | (18,736,000) | (17,663,000) | - | - | - |
| % Net Margin | (1506.3%) | (2881.1%) | (849.1%) | (1449.4%) | (184.4%) | (113.3%) | (146.6%) | (245.3%) | (512.2%) | (524.8%) | (349.9%) | (230.7%) | - | - | - |
ViroGates A/S - employee data
ViroGates A/S - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chairman of the Board of Trustees & Managing Director, Co-founder - an XOventure project | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.